The vaccine that HWGB is working on is a repurposed vaccine meaning that it is already in the open market but for something else. Hence Phase 4 trial only requires a sample size of 300 pax. For Stage 1 of the Phase 4 trial they are only trying on 25 pax before expanding it to 300 pax to complete the Phase 4 clinical trial.
Therefore for repurpose vaccines, if the results are good (like in this case) the roll out will be way easier as from a safety and side effects perspective it is already well proven. So imagine what the price of HWGB would be like once Phase 4 is completed in Jan 2021.
Repurposed vaccine sounds promising with its proven safety record and efficacy but to claim is has 100% immune response from the study, I have to give them the benefit of the doubt.
PHASE 4 CLINICAL TRIAL PRIMED FOR STAGE 2 AFTER SUBMISSION OF INTERIM REPORT TO THE FDA
KUALA LUMPUR, 24 December 2020 - HWGB Biotech Sdn Bhd (“HWGB Biotech”), a wholly owned subsidiary of Ho Wah Genting Berhad (“HWGB” or the “Company”) (Bursa Stock Code: 9601), announced E-MO Biology Inc.’s Interim Report of COVID-19 Vaccine Phase 4 Clinical Trial had been successfully submitted to the US Food and Drug Administration (“FDA”) Clinical Trial Gov System on the 23 December 2020 and the approval is expected to be received within the next few working days. HWGB’s joint venture partner, US-based E-MO Biology Inc. (“EBI”), completed the first stage study of Phase 4 clinical trial and is looking for the commencement to the next step of the expanded trial.
The review of the Interim Report by the FDA is on-going for EBI progression to provide a vaccine that will appeal to the public for COVID-19 prevention. By gaining the FDA approval, EBI will be able to embark on to a larger group study with an additional 275 Subjects, which will be stratified by age and race or ethnicity. The breakthrough was announced when the first stage of the study showed that 100% of the Subjects produced an immune response that recognized protein (RdRp) of both poliovirus and SARS-Cov-2 in their blood samples after vaccination.
Managing Director of EBI, Dr. Xie QiYi, said: “We intend to expand the study cohort to a total of 300 Subjects after the success on the pioneering 25 Subjects enrolled. No adverse effects were reported by the enrolled Subjects which proven that we are heading in the right direction and to continue this study on a larger and more diverse group”.
bloody safe to enter. 0.6-0.8rm, because if the vaccine got approval from FDA... BOOMMMM...... Many countries will acquire because demand is high for vaccines now.. Pfizer and Mordena cant be supplying to so many countries. Meanwhile United State will only completely get vaccinated by the end of March2021, so how about other countries before March 2021, they need vaccines too. So get from who? Right now in the USA, the two most famous vaccines are Pfizer and Mordena.. You know who will come next. Just like Gloves, even TOPGLOVE can consume the whole cake... because of the world's demand, and that's why there were other choices like Supermax, Kossan and etc
Dec 24 (Reuters) - Ho Wah Genting Bhd <HOWA.KL>: * JV PRTNER E-MO BIOLOGY INFORMED CO EBI SUBMITTED FIRST STAGE PHASE 4 CLINICAL TRIAL REPORT TO FDA FOR REVIEW
The Board of Directors of Ho Wah Genting Berhad (“HWGB” or “Company”) wishes to announce that EBI had on 23 December 2020, informed the Company that EBI had on even date submitted its first stage phase 4 clinical trial report to FDA for its review before approval is being granted to commence testing on the additional 275 Subjects, which will be stratified by age and race or ethnicity.
**********The approval is expected to be obtained within the next few working days.************
ham, AT i already buy so long from 0.075... just now stuck at esceramic... hwgb just bought but seen it keep dropping... but now the vaccines news seen not so clear as gov keep saying will direct purchase... let wait for the trial report out first....
i also buy sell buy sell on HWGB until our Minister Khairy say will direct purchase vaccines which kill vaccine theme....for local wannabe vaccines distributor.
i offload all vaccine counter and for now buy recovery stock like Genting...AA...Oil and Gas....Green Tech...
Esceram should be moving in tandem with AT. Since AT now officially producing glove....
Monday will be interesting..... But AT got 4 billion share tradable....it mean in order to move at least 5 cent....volume need to be at least 1 billion ....
AT tomorrow fly to Mars already wahahahha. First Batch of Trial started WOOHOO, but anyways HWGB too awaiting its approval from FDA, and you know what will happen next waahahhahah
Ho Wah Genting: Inks new agreement for Phase IV vaccine trials. Ho Wah Genting (HWGB) announced that its wholly owned subsidiary HWGB Biotech SB's (HWGB Biotech) JV partner, US-based E-MO Biology Inc (EBI), entered into a new clinical trial agreement (CTA) with US-based Roderick A. Comunale II MD Inc and America Diagnostics & GeneScan Diagnostics Inc (ADGD). The new CTA is to appoint Roderick A. Comunale II MD Inc as the principal investigator to commence Phase IV clinical research study on the effectiveness of poliomyelitis virus vaccine (PVV) for prevention of COVID-19 using ADGD as the laboratory. (New Straits Times)
Introducing MY's First IPO Fund for Sophisticated Investors!
MQ Chat
New Update. Discover investment communities that resonate with your ideas
MQ Trader
M & A Value Partners IPO Equity Fund has been launched - Targeted 13% Return p.a
Latest Videos
0:17
New IPO: Carlo Rino Group Berhad, a leading fashion retailer of women’s handbags, footwear, and accessories, aims to list on the ACE Market!
MQ Trader 130 views | 22 h ago
0:17
New IPO: A homegrown air fragrance company, Vanzo Holdings Berhad aims to list on the Ace Market!
MQ Trader 236 views | 1 d ago
0:17
New IPO: Winstar Capital Berhad, a specialist in the extrusion of aluminium profiles and fabrication of aluminium ladders aims to list on the ACE Market!
MQ Trader 405 views | 2 d ago
0:17
New IPO: Topvision Eye Specialist Berhad, specializing in medical eye care services aims to list on the ACE Market!
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
lalazai9
1,000 posts
Posted by lalazai9 > 2020-12-22 17:17 | Report Abuse
Gd news 100% effective vaccine coming soon, tmr all in haha